Alector Announces Topline Results from Latozinemab Phase 3 Trial in Individuals with Frontotemporal Dementia Due to a GRN Mutation and Provides Business Update GlobeNewswire October 21, 2025 SOUTH SAN FRANCISCO, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) — Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company focused on developing therapies to counteract the devastating progression of […]

Synchronoss Technologies Announces Third Quarter 2025 Earnings Call Date GlobeNewswire October 21, 2025 BRIDGEWATER, N.J., Oct. 21, 2025 (GLOBE NEWSWIRE) — Synchronoss Technologies Inc. (“Synchronoss” or the “Company”) (Nasdaq: SNCR), a global leader and innovator in Personal Cloud platforms, will hold a conference call on Tuesday, November 4, 2025 at 4:30 p.m. Eastern time (1:30

Vicor Corporation Reports Results for the Third Quarter Ended September 30, 2025 GlobeNewswire October 21, 2025 ANDOVER, Mass., Oct. 21, 2025 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ: VICR) today reported financial results for the third quarter ended September 30, 2025. These results will be discussed later today at 5:00 p.m. Eastern Time, during management's quarterly

Terns Pharmaceuticals Reports Topline 12-week Data from its Phase 2 Trial Evaluating Oral GLP-1 Receptor Agonist TERN-601 in Obesity GlobeNewswire October 21, 2025 Results show maximum placebo-adjusted weight loss of 4.6% with 12% treatment discontinuation due to adverse events Asymptomatic, reversible grade 3 liver enzyme elevations occurred in three participants during post-treatment follow-up period, two

Exagen Inc. to Announce Third Quarter 2025 Financial Results on November 4, 2025 GlobeNewswire October 21, 2025 CARLSBAD, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), a leading provider of innovative autoimmune testing, will release financial results for the quarter ended September 30, 2025, before the market opens on Tuesday, November 4,

The Lovesac Company Appoints Jacob Pat as Chief Technology and Digital Transformation Officer Proven Technology Leader to Enhance the Company's Digital Strategies to Support Growth Objectives GlobeNewswire October 21, 2025 STAMFORD, Conn., Oct. 21, 2025 (GLOBE NEWSWIRE) — The Lovesac Company (Nasdaq: LOVE) (“Lovesac” or the “Company”), the Designed for Life home and technology brand

LifeVantage to Announce First Quarter Fiscal Year 2026 Results on November 4, 2025 GlobeNewswire October 21, 2025 SALT LAKE CITY, Oct. 21, 2025 (GLOBE NEWSWIRE) — LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results

Ceribell to Report Third Quarter 2025 Financial Results on November 4, 2025 GlobeNewswire October 21, 2025 SUNNYVALE, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) — CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that it will release financial results for

Xometry to Announce Third Quarter 2025 Financial Results on November 4, 2025 GlobeNewswire October 21, 2025 NORTH BETHESDA, Md., Oct. 21, 2025 (GLOBE NEWSWIRE) — Xometry, Inc. (NASDAQ: XMTR), the global AI-powered marketplace connecting buyers and suppliers of custom manufacturing, announced it will report its third quarter 2025 financial results before the market opens on

Beyond Meat(R) to Report Third Quarter 2025 Financial Results on November 4, 2025 GlobeNewswire October 21, 2025 EL SEGUNDO, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) — Beyond Meat, Inc. (NASDAQ: BYND) (“Beyond Meat” or “the Company”), a leader in plant-based meat, announced today it will report financial results for the third quarter ended September 27,